Furthermore, the expression of SGLT2 positively correlates with the level of PD-L1 in non–small cell lung cancer (NSCLC) tissues, and high SGLT2 level predicts poor prognosis in NSCLC. This evidence concerns the gene CD274 and non-small cell lung carcinoma.